Events & Training for May 2013

9th Annual PEGS

29 April 2013 - 03 May 2013

Year after year, PEGS challenges attendees to evolve their thinking around the generation, characterization, and clinical application of proteins. Join over 1,200 of your colleagues this April in Boston to make your mark on the rapidly changing landscape of protein and antibody engineering.

Seaport World Trade Center, Boston, MA, USA

http://www.pegsummit.com/PEGS_Content.aspx?id=120724&libID=120672

Cell Symposium on Mitochondria: from Signaling to Disease

05 May 2013 - 07 May 2013

This symposium will capitalize on the growing excitement about the diversity of mitochondrial functions and will include the following topics: mitochondrial dynamics and interactions with other organelles; signaling at mitochondria; diseases arising from mitochondrial dysfunction; mitophagy and mitochondrial quality control; and metabolism and bioenergetics. With this range of topics, which examines mitochondria from a cell biology, mechanistic, and disease perspective, we aim to bring together biologists from various disciplines, facilitating a wide-ranging discussion of emerging themes in mitochondrial biology.

Sheraton Lisboa, Lisbon, Portugal

http://www.cell-symposia-mitochondria.com/index.html

3rd Epigenetics in Drug Discovery conference

08 May 2013 - 10 May 2013

Some key discussions around epigenetics drug discovery at the conference include: 1) The role of epigenetics in human diseases such as cancer, leukaemia, neurodegenerative conditions, neuropsychiatric disorders, inflammation, etc. 2) Novel mechanisms, biomarkers, technologies and diagnostics for epigenetics drug discovery 3) Cutting edge research from GlaxoSmithKline, Epizyme, Genentech, Constellation, Astex, Cellzome, RaNA Therapeutics, Pfizer, Harvard, Massachusetts Institute of Technology, etc.

Hyatt Regency, Boston, MA, USA

http://www.gtcbio.com/component/conference/?file=home&cn=3rd+Epigenetics+in+Drug+Discovery&cid=82&utm_source=3Epigenetics&utm_medium=EventListing&utm_campaign=3epig

Drug Discovery Summit

08 May 2013 - 10 May 2013

This summit will bring together experts from academia and industry to discuss cutting edge research and new technologies and discuss the legal and regulatory strategies involved in the pharmaceutical and biotech fields. The conference also have designated opportunities to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant issues and deals that will affect the industry.

Hyatt Regency, Boston, MA, USA

http://www.gtcbio.com/component/conference/?file=home&cn=Drug+Discovery+Summit&cid=87&utm_source=drugdiscovery%2B&utm_medium=EventListing&utm_content=drugdiscovery%2B&utm_campaign=drugdiscovery%2B

6th Evolution Summit

08 May 2013 - 10 May 2013

The primary objective of the 6th Evolution Summit is to explore the key aspects and issues related to clinical trial best practices and their application as business drivers for innovation and growth. The Summit’s program topics have been pinpointed and validated by senior executives from the clinical trials community as the top critical issues they face.

Ritz-Carlton in Palm Beach, FL, USA

http://www.evolutionsummit.com/Evolution_MP

Orphan Drugs Research and Commercialization Conference

08 May 2013 - 10 May 2013

GTC is proud to announce its inaugural Orphan Drugs Research and Commercialization Conference at a crucial time in the rare disease space. With new therapies emerging in rare disease treatment and exciting partnerships being forged between big pharma and smaller niche companies, it is clear that the field of rare disease and orphan drug is growing. Rather than merely reciting the challenges of orphan drug development, it is time all stakeholders in the community come together to find innovative solutions in order to better serve rare disease patients.

Hyatt Regency, 1 Ave De Lafayette, Boston, MA, USA

http://www.gtcbio.com/component/conference/?file=home&cn=Orphan+Drugs+Research+and+Commercialization&cid=114&utm_source=ConfWebsite&utm_medium=Posting&utm_campaign=OrphanPost

The Next Gen Stem Cell Conference

08 May 2013 - 09 May 2013

Join us for a novel stem cell conference where young investigators will present their work from many different aspects of stem cell research. The meeting is designed to network young investigators with graduate students, post-docs and senior investigators in an intimate setting. There will be a wide range of panels and topics.

Saratoga National Golf Club, Saratoga Springs, NY 12866 USA

http://www.nextgenstemcell.com/

Generics and Patent Strategies

13 May 2013 - 14 May 2013

Presentations and panel discussions hosted by some of the key opinion leaders within the field of generics will provide delegates with the opportunity to address the challenges faced both today and tomorrow. This year’s event tackles some of the regulatory challenges experienced when entering new markets. It will explore how to overcome some of the IP issues faced when challenging patents and takes a detailed look at the pricing pressures surrounding an already saturated marketplace.

The Copthorne Tara Hotel, London, United Kingdom

http://www.smi-online.co.uk/pharmaceuticals/uk/generics-supergenerics-and-patent-strategies?utm_source=P-066&utm_medium=EM%20-%20MM&utm_campaign=GroupMail

18th ISMAR Conference

19 May 2013 - 24 May 2013

The meeting will conists of ten plenary lectures, 96 invited lecturers and 56 oral presentations selected from submitted abstracts are programmed for the event, covering the topics listed below: •Biomolecular Nuclear Magnetic Resonance (NMR) •Solid-sate NMR/Physics/Exotica/Instrumentation •Liquid Methods/Pharma/Small Molecules (Special session on NMR applied to Natural Products and Medicinal Chemistry) •In vivo/Magnetic Resonance Imaging (MRI)/In cell •Electron Paramagnetic Resonance (EPR)/Electron Nuclear Double Resonance (ENDOR)/Dynamic Nuclear Polarization (DNP) •Workshop NMR on Porous Media •Hot Topics session

Rio de Janeiro, Brazil

http://www.ismar2013.net/

ADC Summit 2013

20 May 2013 - 21 May 2013

Antibody drug conjugates are at the forefront of targeted chemotherapy for the treatment of cancer. Anticipated use of ADCs over the next 5-10 years in set to increase by 40-50% specifically within cancer research. This huge surge in programme is down to highly succesful clinical trials and results that indicate a leap forward in targeted therapeutic delivery, with monoclonal antibodies being used as a springboard for this huge success. A unique event held in London, let ADC 2013 show you how and where the latest technologies and clinical data have transformed this field. Hear from recent advances in conjugate chemistry, target selection, novel payload deliveries, future ADC pipelines and regulatory issues.

Copthorne Tara Hotel, Central London, UK

http://www.smi-online.co.uk/pharmaceuticals/uk/adc-summit?utm_source=P-068&utm_medium=EM%20-%20MM&utm_campaign=GroupMail

Pain Therapeutics

20 May 2013 - 21 May 2013

Pain is the primary reason that patients seek medical care and the pain therapeutics industry is currently under financial strain. With this in mind, SMi are very pleased to present our 13th annual Pain Therapeutics conference which will highlight improvements in R&D methods and certifying that drugs being put forward for clinical trials are given the best chance to succeed. The conference will take place on the 20th and 21st of May 2013 and will provide a unique platform to engage with KOLs and esteemed academia in the field of pain therapeutics. With a spotlight on areas such as: current targets for analgesic development, personalised medicine, the cannabinoid approach , imaging modalities, experimental models in early phase clinical development & improving clinical trial success rates, Pain Therapeutics 2013 promises to be a truly unmissable event!

Copthorne Tara Hotel, London, UK

http://www.smi-online.co.uk/pharmaceuticals/uk/pain-therapeutics?utm_source=P-067&utm_medium=EM%20-%20MM&utm_campaign=GroupMail

ADME & Toxicology 2013

30 May 2013 - 31 May 2013

Our ADME & Toxicology 2013 is an international event being hosted in New Delhi, India. This event will focus on the vital role of ADME and Toxicology in identification and design of a successful drug candidate. Our array of Keynote Speakers will give presentations on all areas of ADME and Toxicology backed up by a panel of expert speakers speaking on highly relevant and “hot” topics such as Pharmacogenomics and Drug Safety, In-silico PK/PD, Toxicity and Genotoxicity Modeling, New therapeutic targets, Metabolomics and ADME Optimization for Drug Design/Discovery.

New Delhi, India

http://selectbiosciences.com/conferences/index.aspx?conf=ADMET13